Related Experiment Videos
[Allogeneic bone marrow transplantation of unrelated donors; fewer complication, more donors]
G S Liem1, J J Cornelissen, M Oudshoorn
1Academisch Ziekenhuis Rotterdam-Daniel, Hoed Kliniek, afd. Hematologie.
Nederlands Tijdschrift Voor Geneeskunde
|August 9, 1997
Abstract:
A female patient aged 37 years who suffered from chronic myeloid leukemia received an allogeneic bone marrow transplantation (BMT) from an HLA-matched unrelated donor. No life-threatening complications ensued; 2.5 years after BMT she is still in complete remission. Survival after BMT from an unrelated donor for the time being is still lower than that after BMT from a related donor, but is improving due to better prevention and treatment of opportunistic infections and better selection of registered donors by meticulous HLA matching.